Mark K. Lafferty

416 total citations
14 papers, 344 citations indexed

About

Mark K. Lafferty is a scholar working on Virology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Mark K. Lafferty has authored 14 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 9 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Mark K. Lafferty's work include HIV Research and Treatment (9 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (3 papers). Mark K. Lafferty is often cited by papers focused on HIV Research and Treatment (9 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (3 papers). Mark K. Lafferty collaborates with scholars based in United States, Italy and Nigeria. Mark K. Lafferty's co-authors include Alfredo Garzino‐Demo, Lingling Sun, Wuyuan Lu, Robert C. Gallo, Aaron Christensen-Quick, Luigi Marchionni, Anthony L. DeVico, Joseph Bryant, Norma Jung and Pia Hartmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Mark K. Lafferty

14 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark K. Lafferty United States 9 190 184 65 59 57 14 344
Pamela P. Gumbi South Africa 7 101 0.5× 114 0.6× 27 0.4× 112 1.9× 79 1.4× 8 286
Antoni Tarrats Spain 10 80 0.4× 110 0.6× 41 0.6× 121 2.1× 41 0.7× 15 271
Louise E. Hogan United States 10 171 0.9× 143 0.8× 26 0.4× 150 2.5× 27 0.5× 19 368
Scott F. Purvis United States 8 197 1.0× 145 0.8× 82 1.3× 76 1.3× 44 0.8× 14 305
Costin Tomescu United States 15 350 1.8× 422 2.3× 43 0.7× 168 2.8× 108 1.9× 19 573
Giulia Cassina Italy 9 114 0.6× 72 0.4× 40 0.6× 154 2.6× 65 1.1× 9 302
J.M. Bourez France 6 147 0.8× 189 1.0× 44 0.7× 135 2.3× 20 0.4× 10 360
Yuria Ablanedo‐Terrazas Mexico 10 134 0.7× 134 0.7× 28 0.4× 138 2.3× 56 1.0× 23 340
I. Bourgault France 9 138 0.7× 157 0.9× 51 0.8× 142 2.4× 53 0.9× 16 308
Antigoni Morou Canada 7 90 0.5× 215 1.2× 56 0.9× 73 1.2× 51 0.9× 8 348

Countries citing papers authored by Mark K. Lafferty

Since Specialization
Citations

This map shows the geographic impact of Mark K. Lafferty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Lafferty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Lafferty more than expected).

Fields of papers citing papers by Mark K. Lafferty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark K. Lafferty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Lafferty. The network helps show where Mark K. Lafferty may publish in the future.

Co-authorship network of co-authors of Mark K. Lafferty

This figure shows the co-authorship network connecting the top 25 collaborators of Mark K. Lafferty. A scholar is included among the top collaborators of Mark K. Lafferty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark K. Lafferty. Mark K. Lafferty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zhang, Fuchun, Lingling Sun, Mark K. Lafferty, Joseph B. Margolick, & Alfredo Garzino‐Demo. (2021). Decreased MIP-3α Production from Antigen-Activated PBMCs in Symptomatic HIV-Infected Subjects. Pathogens. 11(1). 7–7. 1 indexed citations
2.
Lafferty, Mark K., Lingling Sun, Aaron Christensen-Quick, Wuyuan Lu, & Alfredo Garzino‐Demo. (2017). Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6+CD4+ T Cells. Viruses. 9(5). 111–111. 25 indexed citations
3.
Lafferty, Mark K., et al.. (2016). Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice. Proceedings of the National Academy of Sciences. 113(46). 13168–13173. 28 indexed citations
4.
Christensen-Quick, Aaron, Mark K. Lafferty, Lingling Sun, et al.. (2016). Human T h 17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection. Journal of Virology. 90(17). 7833–7847. 48 indexed citations
5.
Latinovic, Olga, Mark K. Lafferty, Lingling Sun, et al.. (2015). Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. Pathogens and Disease. 73(8). ftv062–ftv062. 13 indexed citations
6.
Lafferty, Mark K., Lori E. Fantry, Joseph Bryant, et al.. (2013). Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic rats. Pathogens and Disease. 71(1). 81–89. 7 indexed citations
7.
Curreli, Sabrina, Selvi Krishnan, Marvin S. Reitz, et al.. (2013). B cell lymphoma in hiv transgenic mice. Retrovirology. 10(1). 28 indexed citations
8.
Christensen-Quick, Aaron, Mark K. Lafferty, Marco Goicochea, & Alfredo Garzino‐Demo. (2013). β-defensins that bind CCR6: Blunting the permissiveness of Th17 cells to HIV infection (P4432). The Journal of Immunology. 190(Supplement_1). 206.4–206.4. 1 indexed citations
9.
Cocchi, Fiorenza, Anthony L. DeVico, Wuyuan Lu, et al.. (2012). Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases. Proceedings of the National Academy of Sciences. 109(14). 5411–5416. 39 indexed citations
10.
Lehmann, Clara, Mark K. Lafferty, Alfredo Garzino‐Demo, et al.. (2011). 232 Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of Chronically Infected, Treatment-Naïve HIV-1 Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(Supplement 2). 101–101. 1 indexed citations
11.
Lehmann, Clara, Mark K. Lafferty, Alfredo Garzino‐Demo, et al.. (2010). Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients. PLoS ONE. 5(6). e11110–e11110. 76 indexed citations
12.
Yadav, Anjana, Mohammad M. Sajadi, Bruce L. Gilliam, et al.. (2009). Increased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease. Virology. 385(1). 126–133. 28 indexed citations
13.
Lafferty, Mark K., et al.. (2009). CCR6 ligands inhibit HIV by inducing APOBEC3G. Blood. 115(8). 1564–1571. 46 indexed citations
14.
Sun, Lingling, et al.. (2006). CCR6 mediates the intracellular HIV inhibitory activity of human beta-defensin 2. Retrovirology. 3(S1). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026